We are live on ! Find out more
Corriente Advisors

Corriente Advisors Portfolio holdings

AUM $9.5M Turnover 83.33%
1-Year Est. Return 805.26%
This Fund
S&P 500
This Quarter Est. Return
+2.54%
1 Year Est. Return
+805.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8M
AUM Growth
-$134M
Cap. Flow
-$137M
Cap. Flow %
-264.65%
Top 10 Hldgs %
100%
Holding
21
New
6
Increased
–
Reduced
2
Closed
13
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.3 years

Top Buys

Rank Stock Value
1
TFFP icon
TFF Pharmaceuticals
TFFP
+$8.66M
2
SWN icon
Southwestern Energy
SWN
+$7.57M
3
VET icon
Vermilion Energy
VET
+$5.12M
4
CVE icon
Cenovus Energy
CVE
+$4.61M
5
CCJ icon
Cameco
CCJ
+$378K

Sector Composition

Rank Sector Weight
1 Healthcare 55.39%
2 Energy 41.26%
3 Miscellaneous 3.35%
4 Financials 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CUE icon
1
Cue Biopharma
CUE
$34.7M
$13.8M 26.68%
31,613
-17,953
-36% -$6.26M
2019 Q4
7 quarters
SWN icon
2
DELISTED
Southwestern Energy
SWN
$8.59M 16.58%
+1,550,000
New +$7.57M
2021 Q3
0 quarters
TFFP icon
3
DELISTED
TFF Pharmaceuticals
TFFP
$7.87M 15.2%
+40,794
New +$8.66M
2021 Q3
0 quarters
LTRN icon
4
Lantern Pharma
LTRN
$3.89M
$7M 13.51%
625,873
-30,491
-5% -$395K
2021 Q1
2 quarters
VET icon
5
Vermilion Energy
VET
$1.55B
$6.91M 13.34%
+700,000
New +$5.12M
2021 Q3
0 quarters
CVE icon
6
Cenovus Energy
CVE
$48.9B
$5.44M 10.5%
+540,000
New +$4.61M
2021 Q3
0 quarters
CCJ icon
7
Cameco
CCJ
$25.3B
$435K 0.84%
+20,000
New +$378K
2021 Q3
0 quarters
COIN icon
8
Coinbase
COIN
$27B
– –
-40,000
Closed -$10.1M –
CRDF icon
9
Cardiff Oncology
CRDF
$66.3M
– –
-1,383,500
Closed -$9.2M –
CRSP icon
10
CRISPR Therapeutics
CRSP
$3.79B
– –
-20,000
Closed -$3.24M –
DMAC icon
11
DiaMedica Therapeutics
DMAC
$445M
– –
-203,641
Closed -$906K –
HIMX icon
12
Himax Technologies
HIMX
$1.2B
– –
-200,000
Closed -$3.33M –
IRDM icon
13
Iridium Communications
IRDM
$4.46B
– –
-80,000
Closed -$3.2M –
KTOS icon
14
Kratos Defense & Security Solutions
KTOS
$5.06B
– –
-275,738
Closed -$7.86M –
MP icon
15
MP Materials
MP
$6.05B
– –
-110,000
Closed -$4.06M –
QS icon
16
QuantumScape
QS
$1.73B
– –
-337,316
Closed -$9.9M –
RBLX icon
17
Roblox
RBLX
$33.4B
– –
-30,000
Closed -$2.7M –
REPL icon
18
Replimune Group
REPL
$1.81B
– –
-449,879
Closed -$17.3M –
RETA
19
DELISTED
Reata Pharmaceuticals
RETA
– –
-71,115
Closed -$10.1M –
MAXR
20
DELISTED
Maxar Technologies
MAXR
– –
-1,920,333
Closed -$76.7M –

Similar funds

Corriente Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Corriente Advisors held 21 positions worth $51.8M, down 72% from $185M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Corriente Advisors withdrew a net $137M in Q3 2021, closing 13 positions and reducing 2 holdings. Its most notable exit was Maxar Technologies, an estimated $76.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 36% a quarter earlier, followed by Energy and Miscellaneous.

Against the trend, Corriente Advisors opened a new position in TFF Pharmaceuticals worth $7.87M.

  • Corriente Advisors's largest Q3 2021 buy was TFF Pharmaceuticals: 40,794 shares worth $7.87M.
  • Corriente Advisors's biggest Q3 2021 reduction was Cue Biopharma, cutting an estimated $6.26M.
  • Corriente Advisors fully exited Maxar Technologies in Q3 2021, selling an estimated $76.7M.
  • Corriente Advisors's ten largest holdings make up 100% of its $51.8M portfolio in Q3 2021.
  • Corriente Advisors opened 6 new positions and closed 13 in Q3 2021.
  • Corriente Advisors's portfolio value fell 72% quarter-over-quarter to $51.8M.

Based on Corriente Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.